BVS Q1 2024 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$129M+8.7% YoY

Gross Profit

$88M68.3% margin

Operating Income

$5M3.8% margin

Net Income

-$5M-3.8% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

-4.4%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$794M

Total Liabilities

$577M

Stockholders' Equity

$171M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$129M	$119M	+8.7%
Gross Profit	$88M	$74M	+19.6%
Operating Income	$5M	-$92M	+105.4%
Net Income	-$5M	-$139M	+96.5%

Revenue Segments

U.S. Segment

$114M88%

International Segment

$15M12%

Geographic Segments

UNITED STATES

$114M88%

Non-US

$15M12%